FDA commissioner urges US to crack down on drugmakers' patent abuse

Acting FDA Commissioner Janet Woodcock, MD, wrote a letter to the U.S. Patent and Trademark Office Sept. 10, in which she urged the agency to provide more intervention in drugmakers' anti-competition patent practices.